DNAVSLABT• 7 Days (Normalized)
DNA vs LABT (Ginkgo Bioworks Holdings Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 21 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+31.08%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+31.08 pts
DNA outperforming by 31.08 percentage points
DNALABT
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | DNA Price | DNA Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +31.08% | $- | - | |
| Sep 25, 2026 | $10.66 | +33.58% | $- | - | |
| Sep 24, 2026 | $10.25 | +28.45% | $- | - | |
| Sep 23, 2026 | $8.58 | +7.52% | $1.78 | -13.17% | +20.69% |
| Sep 22, 2026 | $9.37 | +17.42% | $1.99 | -2.93% | +20.35% |
| Sep 21, 2026 | $7.98 | +0.00% | $2.05 | +0.00% | +0.00% |